Tandem Diabetes Care
TNDM
75 hedge funds and large institutions have $106M invested in Tandem Diabetes Care in 2018 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 20 increasing their positions, 4 reducing their positions, and 8 closing their positions.
2,602% more capital invested
Capital invested by funds: $3.92M → $106M (+$102M)
413% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 8
400% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 4
79% more funds holding
Funds holding: 42 → 75 (+33)
31.3% more ownership
Funds ownership: 16.41% → 47.71% (+31%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$15.3M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$7.25M |
| 3 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$7.25M |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$4.34M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$449K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$123K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$85.6K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$65K |
| 5 |
VF
Virtu Financial
New York
|
-$64K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
76
Alyeska Investment Group
Chicago,
Illinois
| – | -$449K | -139,196 | Closed |
|
|
SM
77
Sabby Management
Miami Beach,
Florida
| – | -$65K | -27,487 | Closed |
|
|
VF
78
Virtu Financial
New York
| – | -$64K | -27,308 | Closed |
|
79
Group One Trading
Chicago,
Illinois
| – | -$7K | -3,046 | Closed |
|
|
PSC
80
Piper Sandler & Co
Minneapolis,
Minnesota
| – | -$6K | -2,523 | Closed |
|
|
ASN
81
Advisory Services Network
Atlanta,
Georgia
| – | -$1K | -460 | Closed |
|
TNDM Hedge Fund Activity: Q1 2018 in Review
75 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q1 2018, worth a combined $106M — up 2,602% from $3.92M a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new TNDM positions and 8 closed out — a net gain of 33 holders — while 20 added to existing stakes and 4 trimmed.
The largest buyer was First Light Asset Management, opening a new position worth an estimated $15.3M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $449K sold.
- 75 institutional investors held Tandem Diabetes Care (TNDM) as of Q1 2018, up from 42 in Q4 2017.
- Funds reported $106M of Tandem Diabetes Care stock for Q1 2018, up 2,602% quarter-over-quarter.
- 41 funds opened new Tandem Diabetes Care positions in Q1 2018 and 8 closed out, a net change of +33 holders.
- The largest Tandem Diabetes Care buyer in Q1 2018 was First Light Asset Management, an estimated $15.3M added.
- The largest Tandem Diabetes Care seller in Q1 2018 was Alyeska Investment Group, an estimated $449K sold.
Based on aggregated 13F filings for Q1 2018.